These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12415614)

  • 1. The Crohn's associated NOD2 3020InsC frameshift mutation does not confer susceptibility to ankylosing spondylitis.
    D'Amato M; Sorrentino R; Pettersson S
    J Rheumatol; 2002 Nov; 29(11):2470-1. PubMed ID: 12415614
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease.
    Ferreirós-Vidal I; Amarelo J; Barros F; Carracedo A; Gómez-Reino JJ; Gonzalez A
    J Rheumatol; 2003 Jan; 30(1):102-4. PubMed ID: 12508397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
    Ogura Y; Bonen DK; Inohara N; Nicolae DL; Chen FF; Ramos R; Britton H; Moran T; Karaliuskas R; Duerr RH; Achkar JP; Brant SR; Bayless TM; Kirschner BS; Hanauer SB; Nuñez G; Cho JH
    Nature; 2001 May; 411(6837):603-6. PubMed ID: 11385577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CARD15 gene and the classification of Crohn's disease.
    Murillo L; Crusius JB; van Bodegraven AA; Alizadeh BZ; Peña AS
    Immunogenetics; 2002 Apr; 54(1):59-61. PubMed ID: 11976792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARD15 gene mutations are not associated with ankylosing spondylitis.
    van der Paardt M; Crusius JB; de Koning MH; Murillo LS; van de Stadt RJ; Dijkmans BA; Peña AS; van der Horst-Bruinsma IE
    Genes Immun; 2003 Jan; 4(1):77-8. PubMed ID: 12595906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].
    Lakatos L; Lakatos PL; Willheim-Polli C; Reinisch W; Ferenci P; Tulassay Z; Molnár T; Kovács A; Papp J; Szalay F;
    Orv Hetil; 2004 Jul; 145(27):1403-11. PubMed ID: 15320482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's disease: genetic susceptibility, bacteria, and innate immunity.
    Van Heel DA; McGovern DP; Jewell DP
    Lancet; 2001 Jun; 357(9272):1902-4. PubMed ID: 11425408
    [No Abstract]   [Full Text] [Related]  

  • 8. Crohn's associated NOD2 gene variants are not involved in determining susceptibility to multiple sclerosis.
    Sawcer S; Maranian M; Hensiek A; Roxburgh R; Gray J; Compston A
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1157. PubMed ID: 12876263
    [No Abstract]   [Full Text] [Related]  

  • 9. [NOD2: A functional and positional candidate gene in Crohn's disease].
    Folwaczny C; Glas J
    Z Gastroenterol; 2002 Mar; 40(3):205-7. PubMed ID: 11901457
    [No Abstract]   [Full Text] [Related]  

  • 10. NOD2 (CARD15), the first susceptibility gene for Crohn's disease.
    McGovern DP; van Heel DA; Ahmad T; Jewell DP
    Gut; 2001 Dec; 49(6):752-4. PubMed ID: 11709505
    [No Abstract]   [Full Text] [Related]  

  • 11. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
    Bonen DK; Ogura Y; Nicolae DL; Inohara N; Saab L; Tanabe T; Chen FF; Foster SJ; Duerr RH; Brant SR; Cho JH; Nuñez G
    Gastroenterology; 2003 Jan; 124(1):140-6. PubMed ID: 12512038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CARD15 (also known as NOD2) gene in Crohn's disease: are there implications for current clinical practice?
    Colombel JF
    Clin Gastroenterol Hepatol; 2003 Jan; 1(1):5-9. PubMed ID: 15017511
    [No Abstract]   [Full Text] [Related]  

  • 13. [From gene to disease; 'frame shift'-mutation in the CARD15-gene and Crohn's disease].
    van der Linde K; Kuipers EJ; de Rooij FW; Wilson JH
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2539-42. PubMed ID: 12532667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality.
    Guo QS; Xia B; Jiang Y; Qu Y; Li J
    World J Gastroenterol; 2004 Apr; 10(7):1069-71. PubMed ID: 15052696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's disease, mycobacteria, and NOD2.
    Behr MA; Semret M; Poon A; Schurr E
    Lancet Infect Dis; 2004 Mar; 4(3):136-7. PubMed ID: 14998497
    [No Abstract]   [Full Text] [Related]  

  • 16. NOD2 insertion mutation in a Cretan Crohn's disease population.
    Roussomoustakaki M; Koutroubakis I; Vardas EM; Dimoulios P; Kouroumalis EA; Baritaki S; Koutsoudakis G; Krambovitis E
    Gastroenterology; 2003 Jan; 124(1):272-3; author reply 273-4. PubMed ID: 12512064
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammatory bowel disease: Crohn's disease and the success of NODern genetics.
    Newman B; Siminovitch K
    Clin Invest Med; 2003 Dec; 26(6):303-14. PubMed ID: 14690304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [NOD2 gene mutation associated with susceptibility to Crohn's disease. Evidence of an alteration with links genetic and environmental factors].
    Gutiérrez-Ruiz MC; Robles-Díaz G
    Rev Invest Clin; 2001; 53(5):386-7. PubMed ID: 11795102
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a Crohn's disease susceptibility gene.
    Slow E
    Clin Genet; 2001 Sep; 60(3):174-6. PubMed ID: 11595017
    [No Abstract]   [Full Text] [Related]  

  • 20. Significant role of genetics in IBD: the NOD2 gene.
    Cho JH
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S18-22. PubMed ID: 12684585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.